Back

Sacubitril/Allisartan in hyperuricemia

31 August 2025 (14:30 - 14:45)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: new treatments and biomarkers in hypertension Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Wei Zhang

Shanghai Institute of Hypertension of Ruijin Hospital, Shanghai (China)

3 More presentations in this session

Presentation thumbnail
Benefit-harm trade-offs of intensive blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of six pivotal randomized controlled trials.
Doctor X. Guo (Shenyang, CN)
Slides Video
Presentation thumbnail
Duration of blood pressure treatment and risk of major cardiovascular events
Professor K. Rahimi (Oxford, GB)
Slides Video
Presentation thumbnail
ADEL: A population-based study of clinical outcomes of aldosterone dysregulation
Professor R. Thomsen (Aarhus, DK)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Science: new treatments and biomarkers in hypertension
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Angiotensin receptor and neprilysin inhibition for the treatment of hypertension
thumbnail
Congress Session
Late-Breaking Clinical Science: new treatments and biomarkers in hypertension
thumbnail
Congress Presentation
Comparative clinical outcomes on renal function and mortality of uricosuric agents versus xanthine oxidase inhibitors in patients with hyperuricemia and cardiovascular risks

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources